The rise, fall, and resurgence of immunotherapy in type 1 diabetes.
about
Experimental Diabetes Mellitus in Different Animal ModelsTargeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease.Explaining the increased mortality in type 1 diabetes.PI3Kγ Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytesAnimal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes.Immunotherapy for type 1 diabetes.Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.The use of hematopoietic stem cells in autoimmune diseases.Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment.MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset.Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg/Th17 ratio.Simultaneous Recognition of Allogeneic MHC and Cognate Autoantigen by Autoreactive T Cells in Transplant Rejection.PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes.miR-375 controls porcine pancreatic stem cell fate by targeting 3-phosphoinositide-dependent protein kinase-1 (Pdk1).Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumors.
P2860
Q28066824-45A2A490-DD7D-4BB8-A106-31F13D0F9B64Q33739020-7A4A7DE4-E372-4363-8FF4-64D2B3CBE338Q35630698-804E6314-2F88-4F45-8DD1-0A0C1F39D1B2Q35843607-2D9AC880-2DB3-4FD5-AB25-718E9FDE9843Q36247586-5E46C602-5289-4909-872B-304CECC964E3Q36355094-780736A2-54E3-4F36-BC0D-1FFB2495CCD3Q38660322-F276B84F-2ED4-4A87-B40D-34BE84D19E83Q39161927-A4465E1A-DBD7-4463-B66D-66A3A48BC38AQ39242378-8C42CEBC-751C-4796-A24F-130BA04F8EE1Q39777434-7B3A0F16-4F10-431E-89F1-CF5C453FFD94Q40096435-A7F53EFF-C52A-4AB3-91BB-D7437936C679Q47108533-FD938788-1979-4E6F-8B79-BE11C17E5A8AQ47157103-CED96749-F75A-4463-AA1A-66DEFF3BF9F2Q48293644-B17411BF-AA47-497D-97F0-57FAA5D534EEQ48297683-F2A5008D-0CC4-4BDE-BCF3-A74FD41AB8F1Q50702410-E64AE2BA-388D-43D2-8D35-59F9BE48EBDDQ51319533-A29FBB82-4F6E-4582-8DD8-DB3D3DEE4738Q53737984-B74BB9D1-3299-461A-8484-2C39046406A8
P2860
The rise, fall, and resurgence of immunotherapy in type 1 diabetes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The rise, fall, and resurgence of immunotherapy in type 1 diabetes.
@en
type
label
The rise, fall, and resurgence of immunotherapy in type 1 diabetes.
@en
prefLabel
The rise, fall, and resurgence of immunotherapy in type 1 diabetes.
@en
P2093
P50
P1476
The rise, fall, and resurgence of immunotherapy in type 1 diabetes.
@en
P2093
Moufida Ben Nasr
Vera Usuelli
P356
10.1016/J.PHRS.2014.07.004
P577
2014-08-06T00:00:00Z